PPT-Buprenorphine and Opioid Use Disorder

Bruce C Springer MD FASAM ABAM MidState Health Network OPIATE USE DISORDER 125 million people misused prescription opiates in 2015 21 million Americans were recently new opiate misusers in 2015. Daryl Shorter, MD. Staff Psychiatrist. Michael E. . DeBakey. VA Medical Center. March 2, 2017. Objectives . - By the completion of the presentation, learners will be able to:. (1) List risk factors for misuse, diversion, and/or dependence upon opioid medications and benzodiazepines. Daryl Shorter, MD. Staff Psychiatrist. Michael E. . DeBakey. VA Medical Center. March 2, 2017. Objectives . - By the completion of the presentation, learners will be able to:. (1) List risk factors for misuse, diversion, and/or dependence upon opioid medications and benzodiazepines. John e lopes . j. r. .. , . dhs. c. , pa-c. A. ssociate Professor, . Physician Assistant Program. Central Michigan University. and . Project Director. Medication-assisted Treatment Waiver Training Initiative. Angeline Stanislaus, MD. Chief Medical director- adult services. Missouri . Dept. of Mental Health. How many people are dying each day?. 115. Overdoses. Missouri- Total number of opioid related death 2017. Gloria Baciewicz MD. Strong Recovery, Dept of Psychiatry, University of Rochester. 2018. Challenges of the . Opioid Overdose Crisis. The changing nature of the opioid overdose crisis. Opioid use disorder. Challenges of the Opioid Overdose Crisis Gloria Baciewicz MD Strong Recovery, Dept of Psychiatry, University of Rochester 2018 Challenges of the Opioid Overdose Crisis The changing nature of the opioid overdose crisis Medication Assisted Treatment For Opioid Use Disorders Shannon Allen, MD Jade Wellness Center July 19, 2018 Rates of Relapse in Opioid Use Disorders are High Benefits of Medication Assisted Treatments and . M. edication . Assisted Treatment . and . Team . Training in . Rural . Colorado. Behavioral Health Provider Training. Module 3: . Pharmacology of Buprenorphine and Other Drugs. Copyright 2018 Regents of the University of Colorado.  All Rights Reserved. William J. Lorman, JD, PhD, MSN, PMHNP-BC, CARN-AP. V. P. & Chief Clinical Officer, Livengrin Foundation, Inc.. Ass’t. Clinical Professor, Doctoral Nursing Dept., . Drexel University. wlorman@livengrin.org. Brian Grahan, MD, PhD. Addiction Medicine / Internal Medicine. 6/7/2018. Disclosures. This educational initiative is funded by a grant from the Minnesota Department of Human Services. I have no financial interests to disclose. . Patient Assessmen • Establishment of a diagnosis of Opioid Use Disorder (OUD). • Discussion of current opioid use. • Evaluation of patient’s readiness to participate. • Ph Kaylin A . Klie. , MD, MA, FASAM. Addiction Medicine. University of Colorado and Denver Health. ICWB Shared Learning. March 28. th. , 2022. Discussion Today:. Low Dose Buprenorphine Initiation Strategies. Professor, Associate Chair, and Director of Substance Abuse Research Division. Dept. of Psychiatry and Behavioral Neurosciences; and Dept. of Pharmacy Practice. Wayne State University, Detroit, MI, USA. This . project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under contract number HHSH250201600015C. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government..